Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01609088 · ClinicalTrials.gov registry record · NA

Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus

A NA study of Type 2 Diabetes Mellitus, sponsored by Boston University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT01609088 is a NA study of Type 2 Diabetes Mellitus that has completed, run by Boston University. The registered enrollment target is 24 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01609088, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The study will determine whether acute and chronic consumption of a beverage containing erythritol will improve endothelial function in patients with type 2 diabetes mellitus.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Erythritol-containing beverage

Study Locations (1)

Massachusetts

  • Boston University School of Medicine - Boston

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2012-05
Est. Completion 2012-12
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT01609088

The ClinicalTrials.gov registry entry for NCT01609088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Erythritol-containing beverage is the first listed.

NCT01609088 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01609088 about?

NCT01609088 is a clinical study titled "Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus". The study will determine whether acute and chronic consumption of a beverage containing erythritol will improve endothelial function in patients with type 2 diabetes mellitus.

What is the current status of trial NCT01609088?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-05. Estimated completion is 2012-12.

What conditions does trial NCT01609088 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT01609088?

The interventions under investigation include: Erythritol-containing beverage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01609088?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01609088 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.